文献速递衰弱、肌少症与跌倒老年慢病共病管理

肌少症作为衰老相关系统性能量衰竭的表现

Sarcopenia as a manifestation of systemic energetic failure with ageing.
PubMed 文献 · Lancet Healthy Longev · 2026-09-28

本文提出肌少症应理解为系统性能量衰竭的表现,而非单纯骨骼肌内在疾病。肌肉功能是整合生理学的涌现属性,衰老破坏能量需求、氧与底物输送、线粒体ATP转化及利用的协调,导致力量下降、易疲劳、恢复受损和移动障碍。该框架对评估、风险分层和干预有临床意义。

要点

  • 肌少症应视为系统性能量衰竭的表现,而非仅骨骼肌内在病变。
  • 肌肉功能是整合生理的涌现属性,衰老破坏能量供需协调。
  • 易疲劳和恢复能力可作为早期功能障碍指标,风险分层需考虑多系统损害。

核心结论

  • 肌少症更恰当地理解为系统性能量衰竭的表现,肌肉功能是整合生理学的涌现属性。

研究设计与样本

  • 本文为Personal View,提出生理学假说,整合当前证据并生成关于机制、评估和治疗的可检验预测。

主要发现

  • 流行病学数据显示肌肉力量比肌肉质量更紧密关联残疾和死亡。
  • 干预研究表明增加肌肉质量并不能可靠改善功能。
  • 新兴发现表明线粒体性能受调控氧和底物输送的上游生理过程约束。

临床怎么用

  • 易疲劳和恢复能力可提供功能障碍的早期指标。
  • 风险分层应考虑多系统损害。
  • 有效干预应聚焦恢复协调的生理功能,而非仅靶向肌肉组织恢复。

局限性

  • 该框架应视为整合当前证据的生理学假说,尚需可检验预测验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sarcopenia remains underdiagnosed and undertreated, partly because it continues to be mainly conceptualised as a disorder intrinsic to skeletal muscle. Although current definitions incorporate muscle strength and physical performance, they are not intended to explain the integrated physiological processes that underlie age-related impairment of muscle function. In this Personal View, we propose that sarcopenia is more appropriately understood as a manifestation of systemic energetic failure. In this framework, muscle function is considered an emergent property of integrated physiology that progressively deteriorates as ageing disrupts the coordination among energetic demand (determined by neural activation), the delivery of oxygen and metabolic substrates, their mitochondrial transformation into ATP, and their efficient utilisation. The resulting mismatch between physiological demand and available energy manifests clinically as reduced strength in physical performances, increased fatigability, impaired recovery, and mobility disability. Independent lines of evidence have shown that muscle dysfunction reflects a failure of integrated physiological systems rather than isolated tissue degeneration. First, epidemiological data show that muscle strength is more closely linked to disability and mortality than muscle mass. Second, interventional studies show that increasing muscle mass does not reliably improve function. Third, emerging findings indicate that mitochondrial performance is constrained by upstream physiological processes that regulate oxygen and substrate delivery. Reframing sarcopenia considering the failure of these integrated physiological systems has important clinical implications. Fatigability and recovery can provide early indicators of dysfunction, risk stratification should account for multisystem impairment, and effective interventions should focus on restoring coordinated physiological function rather than targeting muscle tissue recovery alone. This framework should be viewed as a physiological hypothesis that integrates current evidence and generates testable predictions regarding the mechanisms, assessment, and treatment of sarcopenia.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Ferrucci L, Donega S, Picca A, et al. Sarcopenia as a manifestation of systemic energetic failure with ageing. Lancet Healthy Longev. 2026. PMID: 42805229. doi:10.1016/j.lanhl.2026.100904

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。